• Archives of Pharmacal Research
• /
• v.27 no.3
• /
• pp.357-360
• /
• 2004

Four crystal forms of ketorolac have been obtained by recrystallization in organic solvents under variable conditions. Different ketorolac polymorphs and pseudo polymorph were characterized by X-ray powder diffraction crystallography (XRD), Differential scanning calorimetry (DSC) and thermogravimetric analysis (TGA). In the dissolution studies in water at $37{\pm}0.5^{\circ}C$ four crystal forms showed different patterns. The solubility of Form I were the highest. The solubility decreased in rank order: Form I> Form II > Form III > Form IV. Form land Form III were shown to have a good physical stability at room temperature for 60 days. However, Form II is converted to Form III and Form IV is converted to Form I after 60 days storage. Therefore, these observations indicate that crystalline polymorphism for ketorolac is readily inter-convertible and the relationship may have to taken into consideration in the formulation of the drug.

• Bulletin of the Korean Chemical Society
• /
• v.30 no.4
• /
• pp.846-848
• /
• 2009

Two modifications of the ${\alpha}\;and\;{\beta}$ forms of propyl mercaptan nickel(II) cluster, [$Ni_6(SCH_2CH_2CH_3)_{12}$], have been synthesized and their crystal structures have been determined by single-crystal X-ray diffraction. The alkyl groups are away from $Ni_6$ ring in $\alpha$ form whereas they are near to the Ni atom in $\beta$ form. The distance of Ni-H in $\beta$ form [2.576(5) $\AA$] is much shorter than that in $\alpha$ form [3.101(2) $\AA$]. In the crystal lattice of $\beta$ form, the whole structure forms a flower shape.

• Journal of Pharmaceutical Investigation
• /
• v.26 no.3
• /
• pp.193-199
• /
• 1996

The polymorphism of biphenyl dimethyl dicarboxylate was investigated by DSC. From product five crystal forms. Form 1, Form 2, Form 3, Form 4, and Form 5, were characterized and three crystal forms. Form 6, Form 7, and Form 8, were prepared with the recrystallization method. The dissolution patterns of these eight crystal farms were also studied, but there was practically no difference in dissolution rate.

• Applied Chemistry for Engineering
• /
• v.24 no.2
• /
• pp.132-137
• /
• 2013

The liquid crystal form with phosphatidylcholine contents containing in the hydrogenated lecithin was confirmed. Composition ingredients of the liquid crystal vesicle were phospholipid, ethanol and water and the rosmarinic acid was encapsulated as index material. The mean particle size of the liquid crystal vesicle appeared to form various particles form 480 nm to $3{\mu}m$ depending upon the lipid composition and ultrasonic handling time. The liquid crystal vesicle compared with the liposome showed a very high encapsulation efficiency. The quantity of liquid crystal vesicle increased with respect to the increased quantity of lipid contents in the hydrogenated lecithin. The result from release experiments of the liquid crystal vesicle containing rosmarinic acid showed that the liquid crystal vesicle releases much less than that of liposome.

• Journal of Pharmaceutical Investigation
• /
• v.33 no.2
• /
• pp.99-103
• /
• 2003

Four different crystal forms of prednisolone, two polymorphic forms and two pseudopolymorphic forms, were obtained by the recrystallization from different organic solvents under varying conditions. The isolated crystal forms were characterized by differential scanning calorimetry (DSC), thermogravimetric analysis (TGA) and X-ray powder diffraction (XRD). Form 1 was the most stable form that had the highest melting point and melt at $250.1^{\circ}C$. Form 2 was a monohydrate and Form 3 was a methanol solvate. The endothermic peak of Form 4 was shown at $230.2^{\circ}C$. When stored at different relative humidity over the period of 3 months, all of the modifications did not undergo transformation. The dissolution patterns of these four modifications were also checked in distilled water at $37{\pm}0.5^{\circ}C$, for 120 minutes. The dissolution rate of Form 4 was highest and those of Form 3, Form 2, Form 1 followed. Form 2, Form 3 and Form 4 had higher dissolution rate than Form 1.

• Journal of Pharmaceutical Investigation
• /
• v.37 no.1
• /
• pp.23-26
• /
• 2007

Two crystal forms of cefuroxime axetil were obtained by the recrystallization from different organic solvents and characterized by differential scanning calorimetry (DSC), X-ray powder diffraction (XRD). It was confirmed that two crystal forms are identical. The dissolution patterns of these two forms were also checked in 0.07 N HCl at $37{\pm}0.5^{\circ}C$, 100 rpm for 180 minutes. The transformation during storage was also studied.

• Journal of Pharmaceutical Investigation
• /
• v.20 no.2
• /
• pp.65-71
• /
• 1990

Some studies reported physicochemical factors of drugs affecting solubility and dissolution rate. However, few have been reported about pharmaceutical application of crystal forms (habits). Therefore, using acetylsalicylic acid and phenacetin as model substances, we monitored the effects of crystal forms on the dissolution rates.

• Journal of the Korean Crystal Growth and Crystal Technology
• /
• v.33 no.4
• /
• pp.158-164
• /
• 2023

The meaning of the diamond crystal structure and the formative beauty of the crystal form were designed from a new perspective and expressed in jewelry. In this study, we examined the literature on the crystal structure of diamonds and analyzed cases of jewelry design based on the formative characteristics of diamond crystal structure. we newly interpreted the meaning and value of diamond crystal structure, and studied the figurative design that can show the aesthetic effect of the crystal structure by designing the diamond crystal structure as jewelry. By presenting jewelry designs that take advantage of the symmetry effect of the diamond crystal structure and the repetition of the sculptural beauty, we hope that the fundamental beauty and cultural meaning of gemstones will be re-recognized.

• Archives of Pharmacal Research
• /
• v.23 no.4
• /
• pp.381-384
• /
• 2000

It is well recognized that physicochemical properties of drugs are affected by the type of polymorphic crystalline form of drugs. Clarithromycin is known to exist in at least three polymorphic crystalline forms. Since conventional means to obtain the most thermodynamically stable form (Form II) for the antibiotics is known to be associated with a low purity of the stable form, we developed a novel method to improve the purity of the crystalline form by a modification of the preparation process. The new method involved a simple recrystallization of clarithromycin in solvents having 5-12 carbon atoms (e.g., hexane and heptane) or ethers with 4-10 carbon atoms (e.g., isopropyl ether) and, thus, less likely to be associated with the problem in purity of resulting crystal. Differential scanning calorimetry and powder X-ray diffraction were used to compare the crystalline form of the resultant powder with Form IIcrystal prepared by the conventional method. The crystal prepared by the new method was identical to Form IIcrystal of the conventional method as evidenced by the lack of the exothermic peak near 11$0^{\circ}C$ in differential calorimetry scan, indicating that Form IIcrystal could be readily prepared by the new process. Therefore, these data indicated that the improvement in the purity of the Form IIcrystal for clarithromycin as well as a significant cost reduction is likely by the novel method.

• Journal of Pharmaceutical Investigation
• /
• v.30 no.4
• /
• pp.289-293
• /
• 2000

Three polymorphic modifications and one amorphous form were prepared by recrystallization under various conditions and characterized by DSC and X-ray crystallography. At $37{\pm}0.5^{\circ}C$, the polymorphic modifications showed significant differences in the dissolution rate. The dissolution rate of Mod. 4, amorphous form, was faster than that of other polymorphic modifications. When all modifications were stored at 52% RH, 95% RH, and in silica gel desiccator, amorphous form was transformed at 95% humidity condition.